Gilead Sciences Inc
GILD
$157.37+2.49%
End of day · as of Oct 15, 2026, 5:17 PM ET
Mkt cap
$160.15B
EV/Sales
6.29
P/E ratio
N/A
FY2025 Revenue
$29.44B
EPS (TTM)
$-2.65
Gross Margin (FY2025)
78.83%
Profit Margin (FY2025)
28.90%
Beta
0.33
Div yield
2.50%
Sector
Healthcare
No recent filings in cache.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B.
Use this GILD research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GILD income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Gilead Sciences Inc (GILD) is a drug manufacturers - general company in the Healthcare sector.
Latest cached Gilead Sciences Inc (GILD) revenue for Dec 31, 2025 was $29.44B. Net income was $8.51B. Statements: https://lician.com/financials/gild
Gilead Sciences Inc (GILD) market capitalization is $160.15B on the latest cached snapshot.
Gilead Sciences Inc (GILD) cached previous close $153.54; day range $156.22 – $157.37; volume 8,266,064. Session quote: https://lician.com/quote/gild
Gilead Sciences Inc (GILD) latest cached earnings event is "GILD earnings" on Oct 29, 2026. Earnings calendar: https://lician.com/earnings